Blood test breakthrough? new study hunts for prostate cancer clues
NCT ID NCT04964271
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find better ways to detect prostate cancer by looking at blood samples. Researchers will test special antibodies to see if they can identify cancer markers in circulating tumor cells. The study includes 40 men with prostate cancer and 20 healthy donors. It is an early-stage, exploratory study, not a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ospedale San Raffaele
Milan, 20132, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart drug deliver a toxic payload to prostate cancer cells?
- Can AI outthink cancer experts? a landmark trial pits five AIs against tumor boards
- Hormone therapy showdown: can an oral pill beat the shot for prostate cancer patients?
- Can a new daily pill slow advanced prostate cancer?
- Immunotherapy combo takes on Hard-to-Treat prostate cancer
- Could a targeted drug delay prostate cancer progression?